Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity
Authors:
Open Access
- 4 May 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
Obesity and its sequelae have a major impact on human health. The stomach contributes to obesity in ways that extend beyond its role in digestion, including through effects on the microbiome. Gastrokine-1 (GKN1) is an anti-amyloidogenic protein abundantly and specifically secreted into the stomach lumen. We examined whether GKN1 plays a role in the development of obesity and regulation of the gut microbiome. Gkn1−/− mice were resistant to diet-induced obesity and hepatic steatosis (high fat diet (HFD) fat mass (g) = 10.4 ± 3.0 (WT) versus 2.9 ± 2.3 (Gkn1−/−) p < 0.005; HFD liver mass (g) = 1.3 ± 0.11 (WT) versus 1.1 ± 0.07 (Gkn1−/−) p < 0.05). Gkn1−/− mice also exhibited increased expression of the lipid-regulating hormone ANGPTL4 in the small bowel. The microbiome of Gkn1−/− mice exhibited reduced populations of microbes implicated in obesity, namely Firmicutes of the class Erysipelotrichia. Altered metabolism consistent with use of fat as an energy source was evident in Gkn1−/− mice during the sleep period. GKN1 may contribute to the effects of the stomach on the microbiome and obesity. Inhibition of GKN1 may be a means to prevent obesity.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD68103)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK089719, DK056863, 1R21DK110263)
- National Institute of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (UL1 TR001108)
- Rainin Foundation
This publication has 42 references indexed in Scilit:
- Health Effects of Overweight and Obesity in 195 Countries over 25 YearsNew England Journal of Medicine, 2017
- The Physiology and Molecular Underpinnings of the Effects of Bariatric Surgery on Obesity and DiabetesAnnual Review of Physiology, 2017
- Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancerJournal of Negative Results in BioMedicine, 2016
- The stomach in health and diseaseGut, 2015
- Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass RegulationCell Metabolism, 2015
- Prevalence of Childhood and Adult Obesity in the United States, 2011-2012JAMA, 2014
- The Effects of Vertical Sleeve Gastrectomy in Rodents Are Ghrelin IndependentGastroenterology, 2013
- Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down‐regulated in gastric carcinoma, and shows high evolutionary conservationThe Journal of Pathology, 2004
- A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosaAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999